epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

J Cosmet Dermatol

Mediterranean diet, omega-3 fatty acids improve acne symptoms in prospective study

July 12, 2024

card-image

Acne severity improved significantly in patients with target ω-3 fatty acid (FA) levels, achieved through a Mediterranean diet and oral supplementation with algae-derived ω-3 FAs.

  • Over 16 weeks, 60 patients without prescription medication (n=23 with comedonal acne, n=37 with papulopustular acne) adhered to a Mediterranean diet, incorporating oral algae-derived ω-3 FA supplementation (600 mg DHA/300 mg EPA week 1-8, 800 mg DHA/400 mg EPA week 8-16). At four follow-up visits (V1-V4), blood EPA/DHA levels were tracked using the HS-omega 3 index (EPA/DHA [%] of total identified fatty acids in erythrocytes; target 8%-11%, deficit <8%, severe deficit <4%), along with clinical assessments and standardized questionnaires.
  • At baseline, 98.3% of patients had an EPA/DHA deficit. Mean HS-omega 3 index rose from 4.9% at V1 to 8.3% at V4 (p<0.001). Comedonal acne showed significantly higher indices than papulopustular acne at V4 (p=0.035). Objective improvements in both inflammatory and non-inflammatory lesions were seen (p<0.001).
  • While self-reported appearance worsened in four patients, overall quality of life improved (p<0.001), particularly in papulopustular acne. No adverse events were reported.

Source:

Guertler A, et al. (2024, July 10). J Cosmet Dermatol. Exploring the potential of omega-3 fatty acids in acne patients: A prospective intervention study. https://pubmed.ncbi.nlm.nih.gov/38982829/

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information